The Recall Desk
SevereFDA (Drugs)·D-0332-2026·Announced 2026-02-11

Rheumacare Capsules Recalled Due to Lead Contamination

Rheumacare capsules (30-count bottles) are being recalled due to lead contamination discovered during manufacturing. The affected product was distributed to one customer in New York and should not be used.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I drug recall with lead contamination. Per the rubric, FDA Class I recalls are never below severity score 4. No deaths or reported illnesses are documented in the source, so the score does not reach Critical (5).

Plain-English summary

HANDELNINE GLOBAL LLC is recalling Rheumacare capsules in 30-count bottles. The product was manufactured by Virgo UAP Pharma Pvt. Ltd. in Ahmedabad, India. Affected lots are CAM040 (expiration 06/30/2029) and CAL079-N (expiration 09/30/2028), with UPC 8904218700313.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The product was found to contain lead.

The affected product was distributed to one customer in New York. The FDA has classified this as a Class I recall.

Consumers with this product should stop using it immediately and contact a healthcare provider if they have taken these capsules. Do not use any remaining product.

The recalled product

Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Manufacturer
HANDELNINE GLOBAL LLC
Category
Drug
Hazard
  • lead-contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot: CAM040
  • Exp. 06/30/2029 Lot: CAL079-N
  • Exp. 09/30/2028

Distribution

Distributed in 1 state:

  • NY

Related recalls

Same category